ArticleMedicine2017

Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older.

Anca Trifan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.